Mechanistic Studies in Neurodegeneration: Further elucidation of GLP-1RAs neuroprotective mechanisms (eg, anti-inflammatory effects, amelioration of cerebral insulin resistance) is warranted, along with evaluation of the neuropsychiatric potential of GLP-1/GIP dual agonists
Retatrutide , a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, is in clinical development
16 A Unique Mechanism Whats particularly intriguing is how allulose triggers GLP-1 release
Miyazaki, S.W
The FDA classifies these medications as Category C for pregnancy, meaning animal studies have shown potential fetal risk, but human data remains limited
Whats more, that self-digestion causes scarring, making the channels permanently narrower, predisposing people to future pancreatitis attacks, thus setting up a vicious cycle